| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |